RxDoctor Payments DataLook up a doctor →

Christopher Anderson, DPM

Foot Surgery · O'Fallon, ILNPI 1790760494

Payments from drug & device makers

$569,600in general payments, 2019–2025

Across 197 payments — averaging $2891.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endo Pharmaceuticals Inc.$321K
  • Biotissue Holdings Inc.$113K
  • Ipsen Innovation$38K
  • Organogenesis Inc.$36K
  • Axogen$34K
  • Bristol Myers Squibb$15K
  • plus $13K from 20 others
$200,121in research payments, 2019–2025

Across 25 payments — averaging $8004.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Integra Lifesciences Corporation$165K
  • Genentech, Inc.$35K

What the payments were for

  • Consulting fees$6,02645%
  • Travel & lodging$3,01923%
  • Food & beverage$3,44526%
  • Education$8697%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$569,600 in reported general payments places this provider in the 95th percentile of 51 foot surgery providers in Illinois.

See all foot surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$141,131
Medicare patients
206
Services billed
5,372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluconazole15$852
Ketoconazole32$525
Diclofenac Sodium14$500
Terbinafine Hcl43$253
Gabapentin11$217
Doxycycline Hyclate23$208
Azithromycin32$105
Amitriptyline Hcl13$103
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$83
Mupirocin17$81
Triamcinolone Acetonide15$64

Paid to pharmacies, not to this prescriber.

Other foot surgery in O'Fallon

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →